Tsukasaki Masayuki, Takayanagi Hiroshi
Department of Immunology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Inflamm Regen. 2022 Sep 2;42(1):27. doi: 10.1186/s41232-022-00213-x.
Osteoclasts, the only cells that can resorb bone, play a central role in bone homeostasis as well as bone damage under pathological conditions such as osteoporosis, arthritis, periodontitis, and bone metastasis. Recent studies using single-cell technologies have uncovered the regulatory mechanisms underlying osteoclastogenesis at unprecedented resolution and shed light on the possibility that there is heterogeneity in the origin, function, and fate of osteoclast-lineage cells. Here, we discuss the current advances and emerging concepts in osteoclast biology.
破骨细胞是唯一能够吸收骨组织的细胞,在骨稳态以及骨质疏松症、关节炎、牙周炎和骨转移等病理条件下的骨损伤中发挥着核心作用。最近使用单细胞技术的研究以前所未有的分辨率揭示了破骨细胞生成的调控机制,并揭示了破骨细胞谱系细胞在起源、功能和命运方面存在异质性的可能性。在这里,我们讨论破骨细胞生物学的当前进展和新兴概念。